People with certain conditions are now eligible for one extra dose of a COVID-19 vaccine. According to the United States Food and Drug Administration (FDA), another dose can boost protection against COVID-19.
Cancer patients and healthcare workers are among those who qualify for another dose. Patients undergoing activemesothelioma treatmentare also eligible.
额外剂量的添加保护对于间皮瘤患者很重要。万博专业版这些患者有higher than average COVID-19 risks。Getting vaccinated may provide peace of mind for many of these patients.
哪些疫苗被批准用于额外剂量？
At this time, all three COVID-19 vaccines have been authorized for an additional dose in qualified patients. For Pfizer and Moderna vaccines, that additional dose will be a third dose. For the Johnson & Johnson vaccine, the authorization allows a second dose.
FDA调节因子在进行这些确定之前评估研究数据。他们发现证据表明，接种疫苗的人的Covid-19保护随着时间的推移而降低。监管机构还证明了补充疫苗剂量可提高对Covid-19的保护。
通过考虑到这些信息，FDA确定了补充剂量超过风险的益处。但是，FDA的决定仅授权额外的剂量。疫苗制造商需要在未来寻求进一步批准额外剂量。
谁有资格获得补充疫苗剂量？
Some individuals who previously received COVID-19 vaccines are now eligible for an additional dose.
有些患者可能难以获得他们收到的第一个Covid-19疫苗的额外剂量。在这种情况下，FDA已授权“混合和匹配”方法。如果需要，患者可以获得另外的任何可用Covid-19疫苗的剂量，无论它与其第一剂量匹配。
间皮瘤患者是否万博专业版应达到另一个Covid-19疫苗剂量？
Mesothelioma patients have a lot to consider when it comes to vaccination. First and foremost, COVID-19 poses未接种疫苗的间皮瘤患者的严重风险万博专业版， 包含：
- A higher mortality rate than the general population
- 比一般人群更高的并发症率
- 高等的住院率比一般人群
许多患者根据这些风险转向疫苗。此外，最近围绕间皮瘤患者和Covid-19疫苗接种的数据很有前途。万博专业版
At least one mesothelioma specialist saw much lower rates of COVID-19 infection in vaccinated mesothelioma patients versus unvaccinated. Study data also indicates the first two Pfizer vaccine doses provide protection against COVID-19. Furthermore, recent data shows improved protection after an additional dose of the vaccine.
Patients may also want to consider recommendations from official bodies, such as the Centers for Disease Control and Prevention (CDC). The CDC recommends an additional vaccine dose for individuals with moderately to severely compromised immune systems. This includes individuals receiving cancer treatment, such as mesothelioma treatment.
Any mesothelioma patient considering an additional vaccine dose should speak with their oncology team. The team can help the patient weigh the benefits and risks of the supplementary dose.
